Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simak Ali

Showing results (41-50 of 111) with videos related to

Pageof 12
Sort By:
Chemmedchem|January 27, 2018
Corrigendum: Inhibitor Selectivity for Cyclin-Dependent Kinase 7: A Structural, Thermodynamic, and Modelling StudyPascale Hazel, Sebastian H B Kroll, Alexander Bondke, et al.
Chemmedchem|January 27, 2017
Inhibitor Selectivity for Cyclin-Dependent Kinase 7: A Structural, Thermodynamic, and Modelling StudyPascale Hazel, Sebastian H B Kroll, Alexander Bondke, et al.
The Journal of Biological Chemistry|November 24, 2004
ICI182,780 induces p21Waf1 gene transcription through releasing histone deacetylase 1 and estrogen receptor alpha from Sp1 sites to induce cell cycle arrest in MCF-7 breast cancer cell lineRana Varshochi, Faezah Halim, Andrew Sunters, et al.
Oncogene|February 23, 2022
Induction of APOBEC3-mediated genomic damage in urothelium implicates BK polyomavirus (BKPyV) as a hit-and-run driver for bladder cancerSimon C Baker, Andrew S Mason, Raphael G Slip, et al.
Breast Cancer Research and Treatment|January 26, 2019
Dissecting the predictive value of MAPK/AKT/estrogen-receptor phosphorylation axis in primary breast cancer to treatment response for tamoxifen over exemestane: a Translational Report of the Intergroup Exemestane Study (IES)-PathIESZsolt Szijgyarto, Koen D Flach, Mark Opdam, et al.
Oncogene|August 31, 2004
Silencing of androgen-regulated genes using a fusion of AR with the PLZF transcriptional repressorJoanna Pike, David Holmes, Tahereh Kamalati, et al.
Breast Cancer Research and Treatment|August 13, 2016
Prognostic significance of androgen receptor expression in invasive breast cancer: transcriptomic and protein expression analysisMohammad A Aleskandarany, Rezvan Abduljabbar, Ibraheem Ashankyty, et al.
Nucleic Acids Research|November 7, 2006
ZNF366 is an estrogen receptor corepressor that acts through CtBP and histone deacetylasesJorge Lopez-Garcia, Manikandan Periyasamy, Ross S Thomas, et al.
Breast Cancer Research and Treatment|January 7, 2018
Correction to: Tumour suppressor EP300, a modulator of paclitaxel resistance and stemness, is downregulated in metaplastic breast cancerMuhammad Asaduzzaman, Stephanie Constantinou, Haoxiang Min, et al.
Breast Cancer Research and Treatment|March 26, 2017
Tumour suppressor EP300, a modulator of paclitaxel resistance and stemness, is downregulated in metaplastic breast cancerMuhammad Asaduzzaman, Stephanie Constantinou, Haoxiang Min, et al.
Pageof 12

Showing results (41-50 of 111) with videos related to

Sort By:
Pageof 12
Chemmedchem|January 27, 2018
Corrigendum: Inhibitor Selectivity for Cyclin-Dependent Kinase 7: A Structural, Thermodynamic, and Modelling StudyPascale Hazel, Sebastian H B Kroll, Alexander Bondke, et al.
Chemmedchem|January 27, 2017
Inhibitor Selectivity for Cyclin-Dependent Kinase 7: A Structural, Thermodynamic, and Modelling StudyPascale Hazel, Sebastian H B Kroll, Alexander Bondke, et al.
The Journal of Biological Chemistry|November 24, 2004
ICI182,780 induces p21Waf1 gene transcription through releasing histone deacetylase 1 and estrogen receptor alpha from Sp1 sites to induce cell cycle arrest in MCF-7 breast cancer cell lineRana Varshochi, Faezah Halim, Andrew Sunters, et al.
Oncogene|February 23, 2022
Induction of APOBEC3-mediated genomic damage in urothelium implicates BK polyomavirus (BKPyV) as a hit-and-run driver for bladder cancerSimon C Baker, Andrew S Mason, Raphael G Slip, et al.
Breast Cancer Research and Treatment|January 26, 2019
Dissecting the predictive value of MAPK/AKT/estrogen-receptor phosphorylation axis in primary breast cancer to treatment response for tamoxifen over exemestane: a Translational Report of the Intergroup Exemestane Study (IES)-PathIESZsolt Szijgyarto, Koen D Flach, Mark Opdam, et al.
Oncogene|August 31, 2004
Silencing of androgen-regulated genes using a fusion of AR with the PLZF transcriptional repressorJoanna Pike, David Holmes, Tahereh Kamalati, et al.
Breast Cancer Research and Treatment|August 13, 2016
Prognostic significance of androgen receptor expression in invasive breast cancer: transcriptomic and protein expression analysisMohammad A Aleskandarany, Rezvan Abduljabbar, Ibraheem Ashankyty, et al.
Nucleic Acids Research|November 7, 2006
ZNF366 is an estrogen receptor corepressor that acts through CtBP and histone deacetylasesJorge Lopez-Garcia, Manikandan Periyasamy, Ross S Thomas, et al.
Breast Cancer Research and Treatment|January 7, 2018
Correction to: Tumour suppressor EP300, a modulator of paclitaxel resistance and stemness, is downregulated in metaplastic breast cancerMuhammad Asaduzzaman, Stephanie Constantinou, Haoxiang Min, et al.
Breast Cancer Research and Treatment|March 26, 2017
Tumour suppressor EP300, a modulator of paclitaxel resistance and stemness, is downregulated in metaplastic breast cancerMuhammad Asaduzzaman, Stephanie Constantinou, Haoxiang Min, et al.
Pageof 12